Skip to main content

Published locations for Increased B-cell lymphoma risk with JAK1/2 inhibitors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Increased B-cell lymphoma risk with JAK1/2 inhibitors

User login

  • Reset your password
  • /content/increased-b-cell-lymphoma-risk-jak1/2-inhibitors
  • /hematologynews/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2
  • /jcso/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2-inhibitors
  • /oncologypractice/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2
  • /hematologynews/nhlhub/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2
  • /hematology-oncology/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2
  • /b-cell-lymphoma-icymi/article/172182/myelodysplastic-syndrome/increased-b-cell-lymphoma-risk-jak1/2